Drugs Made In America Acq... (DMAAR)
NASDAQ: DMAAR
· Real-Time Price · USD
0.13
-0.02 (-13.33%)
At close: May 23, 2025, 2:37 PM
0.13
0.00%
After-hours: May 23, 2025, 02:37 PM EDT
Drugs Made In America Acquisition Rights Revenue
Drugs Made In America Acquisition Rights reported an annual revenue of $0, reflecting a undefined% growth. For the quarter ending December 31, 2024, Drugs Made In America Acquisition Rights generated $0 in revenue.
Revenue (ttm)
-
Revenue Growth
undefined%
Price / Sales Ratio
undefined
Revenue / Employee
-
Employees
undefined
Market Cap
2.7M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|